Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trana Discovery has developed a proprietary drug discovery technology that enables identification of compounds which inhibit the use of organism-specific transfer RNA by bacterial, viral, or fungal pathogens. The company’s approach represents a novel mechanism distinct from traditional antimicrobial targets. No clinical results are available; the company operates primarily as a platform provider and collaborator with pharma/agriculture partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trana Discovery.